Update on adjuvant treatment in HER2+ BC.
Joseph GLIGOROV
VAB and VAE: To sample or to excise?
Gregory LENCZNER
What’s your take on new breast cancer treatments?
Georgia DEMETRIOU
oncologist, Johannesburg, SA
What are the options in HER2 postive breast cancer treatments are we moving to t-DXd in first line?
Hassan GHAZAL
oncologist, Dubai
What’s the prognostic value of PET scan imaging as a predictive tool for ER + breast cancer patients?
Willy Vangu
nuclear medicine, Johannesburg, South Africa